DYN
Dyne Therapeutics Inc

2,663
Mkt Cap
$2.53B
Volume
2.26M
52W High
$25.00
52W Low
$6.36
PE Ratio
-4.41
DYN Fundamentals
Price
$16.15
Prev Close
$15.62
Open
$14.78
50D MA
$17.59
Beta
1.83
Avg. Volume
1.81M
EPS (Annual)
-$3.37
P/B
3.33
Rev/Employee
$0.00
$1,599.74
Loading...
Loading...
News
all
press releases
Dyne Therapeutics (NASDAQ:DYN) Shares Down 6.6% After Earnings Miss
Dyne Therapeutics (NASDAQ:DYN) Trading Down 6.6% After Earnings Miss...
MarketBeat·6h ago
News Placeholder
More News
News Placeholder
Investment Firm Adds Nearly $4 Milllion Worth of DYN Shares, According to Recent SEC Filing
Key Points209,523-share increase in Dyne Therapeutics; estimated transaction value $3.97 million (based on quarterly average pricing...
Nasdaq News: Markets·8h ago
News Placeholder
Dyne Therapeutics Posts Wider Loss In Q4
(RTTNews) - Dyne Therapeutics, Inc. (DYN) reported a fourth quarter net loss of $112.0 million, or $0.76 per share compared with a net loss of $89.5 million, or $0.88 per share, a year ago. Research...
Nasdaq News: Markets·12h ago
News Placeholder
Dyne Therapeutics, Inc. (NASDAQ:DYN) Given Average Recommendation of "Moderate Buy" by Analysts
Shares of Dyne Therapeutics, Inc. (NASDAQ:DYN - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the eighteen brokerages that are presently covering the firm, Marketbeat...
MarketBeat·3d ago
News Placeholder
Aberdeen Group plc Purchases 72,770 Shares of Dyne Therapeutics, Inc. $DYN
Aberdeen Group plc raised its position in shares of Dyne Therapeutics, Inc. (NASDAQ:DYN - Free Report) by 15.0% in the 3rd quarter, according to its most recent 13F filing with the Securities and...
MarketBeat·10d ago
News Placeholder
Dyne Therapeutics (DYN) to Release Earnings on Thursday
Dyne Therapeutics (NASDAQ:DYN) will be releasing its Q4 2025 earnings before the market opens on Thursday, February 26. (View Earnings Report at...
MarketBeat·12d ago
News Placeholder
Dyne Therapeutics Becomes Oversold (DYN)
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a...
Nasdaq News: Markets·12d ago
News Placeholder
DYN Crosses Below Key Moving Average Level
In trading on Tuesday, shares of Dyne Therapeutics Inc (Symbol: DYN) crossed below their 200 day moving average of $14.86, changing hands as low as $14.67 per share. Dyne Therapeutics Inc shares are...
Nasdaq News: Markets·13d ago
News Placeholder
Candriam S.C.A. Has $10.55 Million Stock Position in Dyne Therapeutics, Inc. $DYN
Candriam S.C.A. increased its holdings in Dyne Therapeutics, Inc. (NASDAQ:DYN - Free Report) by 59.1% during the third quarter, according to its most recent 13F filing with the Securities and...
MarketBeat·20d ago
News Placeholder
Keros Therapeutics vs. Dyne: Which DMD Biotech Has More Upside?
Keros Therapeutics advances KER-065 toward DMD trials, trims costs, and extends its cash runway as investors weigh it against Dyne???s deeper pipeline
Zacks·1mo ago
<
1
2
...
>

Latest DYN News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.